ICU Medical's General Counsel Sells — The Smiths Integration Is Almost Done, the Proof Isn'tICU Medical's General Counsel Sells — The Smiths Integration Is still playing out.

ICU Medical's General Counsel Ruth Sanzone sold 2,447 shares worth ~$304,000 in an open-market transaction. While the Smiths Medical integration nears completion with manufacturing consolidation largely finished, the company faces headwinds from ~$1 billion in net debt, tariff pressures of $40-50 million annually, and a stock down 16% over the past year. The company's ability to achieve its 43% gross margin target and 2x leverage goal remains unproven after three years.

06/10/2026, 7:36 PM • The Motley Fool

EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks

The Iran-Israel conflict and potential Strait of Hormuz disruption are creating supply chain pressures on medical supplies through petrochemical derivatives. Key inputs like naphtha and methanol used in pharmaceutical packaging and drug synthesis are experiencing price increases. While hospitals haven't yet felt the impact, analysts expect cost pressures on IV bags, tubing, and other critical consumables to surface within 2-4 weeks as the disruption ripples through supply chains.

03/25/2026, 8:01 AM • Benzinga

Intravenous (IV) Solutions Market Size to Reach USD 29.47 Billion by 2035 Due to the Increasing Prevalence of Chronic Diseases Globally | SNS Insider

The global IV solutions market is projected to grow from USD 13.35 billion in 2025 to USD 29.47 billion by 2035, with a CAGR of 8.24%. Growth is driven by increasing prevalence of chronic diseases, rising hospital admissions, and growing demand for parenteral nutrition and critical care solutions. The U.S. market alone is expected to reach USD 8.39 billion by 2035. North America leads with 40.70% market share, while Asia-Pacific shows the fastest growth at 9.46% CAGR.

03/13/2026, 4:30 AM • GlobeNewswire

[Latest] Global Intravenous Infusion Pump Market Size/Share Worth USD 14.02 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global intravenous infusion pump market was valued at USD 6.72 billion in 2025 and is projected to reach USD 14.02 billion by 2035, growing at a CAGR of 7.6%. Growth is driven by increasing chronic diseases, aging populations, technological advancements in smart pumps, and rising demand for precise medication delivery in hospitals and home care settings.

03/09/2026, 6:30 PM • GlobeNewswire

ICU Medical (ICUI) Q2 EPS Jumps 40%

ICU Medical reported Q2 2025 earnings with a significant EPS beat of $2.10, exceeding analyst expectations by 40%. Despite strong profitability, the company faces challenges from regulatory issues, tariffs, and segment performance variability, leading to cautious FY2025 guidance.

08/07/2025, 9:15 PM • The Motley Fool